Insider transactions
Director Jesse Chen executed a series of sales of Axt Inc (NASDAQ: AXTI) common stock on March 12 and March 13, 2026, disposing of a total of 14,086 shares for about $700,039. On March 12, Chen sold 6,003 shares in multiple transactions at prices ranging from $46.72 to $49.825. On March 13, he sold 8,083 shares in multiple transactions at prices ranging from $48.39 to $51.38. After these transactions, Chen directly holds 109,526 shares of Axt Inc.
Share price and valuation note
The sales occurred while AXTI shares were trading close to a 52-week high of $51.98, following a one-year return of 2,614%. According to InvestingPro analysis cited in company coverage, the stock appears overvalued relative to its Fair Value; that analysis also references 18 additional ProTips available to subscribers on the platform.
Company guidance adjustment
In related corporate news, AXT adjusted its fourth-quarter revenue guidance to a range of $22.5 million to $23.5 million, down from a prior estimate of $27 million to $30 million. Management attributed the downward revision to a reduction in export permits for indium phosphide from China’s Ministry of Commerce, a development that the company said limits its ability to fulfill certain customer orders.
Analyst moves and market reaction
Following the guidance change and demand commentary, Craig-Hallum raised its price target on AXT from $10 to $26 and maintained a Buy rating, citing strong demand and potential constraints that could hamper competitors. By contrast, B. Riley moved to downgrade AXT from Buy to Neutral on valuation concerns, while still raising its price target to $18.
Sector notes
Additional analyst updates noted in the coverage include Needham’s upgrade of Nova Measuring Instruments to Buy with a $500 price target, citing strong global execution and positioning to benefit from a projected increase in China’s memory wafer fab equipment by 2026. Needham also upgraded Ichor Holdings to Buy with a $36 price target, characterizing Ichor as a potential derivative play on larger semiconductor equipment makers.
What is known and what is not
The reported facts here are specific: the exact share counts, price ranges, resulting direct holdings for the director, the revised revenue guidance figures, the stated reason for the guidance change, and the analyst rating and price-target moves. The reporting does not provide commentary from Chen or management beyond the company attribution of the guidance revision to the export-permit reduction.
Takeaway
The combination of an insider sale, a downward revision to quarter-end revenue guidance tied to export-permit limitations, and divergent analyst responses underscores active reassessment across the semiconductor equipment supply chain. The details reported are limited to the transactions, the guidance change, the cited cause for that change, and the subsequent analyst actions noted above.
Key points
- Jesse Chen sold 14,086 AXT shares on March 12-13, 2026, for about $700,039 and now directly owns 109,526 shares.
- AXT lowered Q4 revenue guidance to $22.5M - $23.5M from $27M - $30M, attributing the cut to reduced export permits for indium phosphide from China’s Ministry of Commerce.
- Analysts reacted variably: Craig-Hallum raised its price target to $26 and kept a Buy rating; B. Riley downgraded to Neutral but increased its target to $18. Needham upgraded NVMI and Ichor with new targets.
Risks and uncertainties
- Export-permit limitations for indium phosphide from China’s Ministry of Commerce have already impacted AXT’s ability to meet customer demand, creating near-term revenue uncertainty for the company and potential supply constraints for customers - impacting the semiconductor equipment supply chain.
- Valuation concerns noted by at least one analyst introduce uncertainty about investor appetite despite recent share-price gains; this affects market sentiment for AXTI.